Longeveron Inc. (LGVN)
NASDAQ: LGVN
· Real-Time Price · USD
1.31
0.04 (3.15%)
At close: Jun 26, 2025, 3:59 PM
1.27
-2.97%
After-hours: Jun 26, 2025, 07:57 PM EDT
3.15% (1D)
Bid | 1.25 |
Market Cap | 19.66M |
Revenue (ttm) | 2.23M |
Net Income (ttm) | -16.92M |
EPS (ttm) | -1.35 |
PE Ratio (ttm) | -0.97 |
Forward PE | -1.09 |
Analyst | Buy |
Ask | 1.3 |
Volume | 136,509 |
Avg. Volume (20D) | 131,162 |
Open | 1.30 |
Previous Close | 1.27 |
Day's Range | 1.25 - 1.31 |
52-Week Range | 1.14 - 6.40 |
Beta | 0.21 |
About LGVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LGVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LGVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-0.65%
Longeveron shares are trading higher after the com...
Unlock content with
Pro Subscription
11 months ago
+0.87%
Longeveron shares are trading higher after the company announced study results from the CLEAR MIND Phase 2a clinical trial of Lomecel-B in mild Alzheimer's disease, meeting its key objectives to advance data supporting a favorable benefit/risk profile.